ASH 2021 Highlights

According to results presented at the 2021 ASH Annual Meeting and Exposition, new sequencing technologies may overcome previous limitations of circulating tumor DNA (ctDNA) profiling in patients with central nervous system (CNS) lymphoma. Using ultrasensitive sequencing, researchers were able to diagnose the disease based on ctDNA mutational profiles.

Results 1 - 1 of 1